Sonia Ktari | Medical Bacteriology | Best Researcher Award

Assist. Prof. Dr. Sonia Ktari | Medical Bacteriology | Best Researcher Award

Assist. Prof. Dr. Sonia Ktari, Faculty of Medicine of Sfax, Tunisia

Dr. Sonia Ktari Chaari is a dedicated Assistant Professor of Microbiology at the Faculty of Medicine, University of Sfax, Tunisia. She plays a key role at the Laboratory of Microorganisms and Human Pathologies, CHU Habib Bourguiba. Her expertise lies in bacterial resistance, molecular epidemiology, and microbiological diagnostics. With over two decades of academic pursuit and scientific inquiry, she has contributed significantly to the understanding of hospital-acquired infections and emerging resistant strains. Dr. Ktari has co-authored numerous high-impact journal publications and has supervised multiple theses in microbiology and health sciences. Her scholarly approach integrates molecular biology with data-driven research, as demonstrated by her recent specialization in statistics and data analysis. As a mother of two and an accomplished scientist, Dr. Ktari exemplifies balance and excellence in academia, earning respect both nationally and internationally for her contributions to medical bacteriology.

Profile 

Scopus

Suitability Summary for Research for Best Researcher Award: Sonia Ktari Chaari

Sonia Ktari Chaari is a highly accomplished microbiologist and Assistant Professor at the Faculty of Medicine of Sfax, Tunisia. Her strong academic foundation, including a PhD in Biological Engineering and a recent Habilitation to Direct Research (HDR), reflects her commitment to advancing scientific knowledge. She also holds a professional master’s degree in statistics and data analysis, underlining her proficiency in applying rigorous quantitative methods to health sciences research.

Her research expertise centers on microbiology, infectious diseases, and antimicrobial resistance, a critical and globally relevant field. Sonia has made significant contributions to understanding hospital-associated infections, molecular epidemiology, and antibiotic resistance mechanisms, as demonstrated by her numerous publications in reputable, peer-reviewed international journals with respectable impact factors. Her work on nosocomial outbreaks and antibiotic-resistant bacterial strains such as Klebsiella pneumoniae, Salmonella enterica, and Streptococcus pneumoniae showcases both applied and fundamental research that addresses urgent public health challenges.

🎓 Education 

Dr. Sonia Ktari holds a comprehensive academic background in biological sciences. She earned her Habilitation to Direct Research (HDR) in Biological Sciences in 2023 from the Faculty of Sciences of Sfax. She further diversified her skillset by obtaining a Professional Master’s in Statistics and Data Analysis for Health Sciences from the Faculty of Medicine of Sfax the same year. Her foundational journey includes a PhD and Master’s in Biological Engineering from the National School of Engineers of Sfax in 2008 and 2003, respectively. Prior to that, she acquired a Bachelor’s Degree and a DEUG in Natural Sciences from the Faculty of Sciences of Sfax. Her early academic formation was rooted in the Experimental Sciences, completing her Baccalaureate in 1997. Dr. Ktari’s interdisciplinary education equips her with both deep scientific knowledge and modern analytical tools, empowering her to lead high-impact research in microbiology and infectious disease control.

💼 Professional Experience

With over a decade of academic and research experience, Dr. Sonia Ktari has been an integral faculty member at the University of Sfax, Tunisia, since 2014. As Assistant Professor in Microbiology, she has developed and delivered courses in Genetics, Molecular Biology, Bioinformatics, and Bacterial Typing for both undergraduate and postgraduate students. Her pedagogical expertise extends to supervising practical workshops and creating laboratory manuals that enhance applied learning. In research supervision, Dr. Ktari has mentored numerous Master’s and undergraduate theses, and co-supervised a PhD in Molecular and Cellular Biology. Her laboratory work, housed in CHU Habib Bourguiba’s microbiology division, focuses on hospital pathogen surveillance and molecular diagnostics. She collaborates closely with clinical and international research teams, contributing to high-impact investigations of antibiotic resistance and nosocomial outbreaks. Her multifaceted experience bridges teaching, research, and clinical microbiology, shaping her as a leader in the field of medical bacteriology.

🏅 Awards and Recognition

Dr. Sonia Ktari has received widespread recognition for her impactful contributions to medical bacteriology. Her scientific publications in top-tier journals such as the Journal of Antimicrobial Chemotherapy and Microbial Drug Resistance have brought international attention to Tunisia’s efforts in combatting bacterial resistance. Her studies on multi-drug resistant pathogens like Klebsiella pneumoniae, Pseudomonas aeruginosa, and Streptococcus pneumoniae have become critical references in clinical microbiology. In acknowledgment of her growing influence in microbiological research and her ability to mentor young scientists, she earned her Habilitation to Direct Research in 2023. She is a trusted co-author in interdisciplinary teams and often contributes to collaborative projects with global epidemiology centers. Her dedication to academic excellence and laboratory precision has also garnered accolades within her institution and among the broader research community. Dr. Ktari’s standing as a scholar makes her a deserving candidate for prestigious international research awards.

🌍 Research Skills On Medical Bacteriology

Dr. Ktari’s research proficiency lies at the intersection of molecular microbiology, antimicrobial resistance, and genomic epidemiology. She has specialized skills in molecular subtyping methods, bacterial genome analysis, and clinical diagnostics. Her work involves tracking the genetic evolution and resistance mechanisms of nosocomial pathogens such as Salmonella enterica, Klebsiella pneumoniae, and Streptococcus pneumoniae. She effectively uses statistical and computational tools to analyze large datasets, thanks to her Master’s in Health Data Analysis. Dr. Ktari is proficient in designing and executing PCR, sequencing protocols, and resistance gene detection. Additionally, her capabilities in supervising multidisciplinary teams and translating research into clinical practice enhance her relevance in both academic and hospital-based microbiological settings. Her ability to lead investigations into hospital outbreaks and resistance spread highlights her vital contribution to public health microbiology.

📖 Publication Top Notes

Title: Genomic analysis of Brucella melitensis isolates recovered from humans in south Tunisia over 35 years between 1988 and 2022
Authors: (Not provided in your snippet)
Citation count: 1 citation
Year: 2025
Journal: BMC Microbiology
Access: Open access

Title: Molecular epidemiology of a multidrug-resistant Shigella sonnei outbreak in Tunisia (2022–2023) using whole-genome sequencing
Authors: (Not provided in your snippet)
Citation count: 0 citations
Year: 2025

Wing Hong Seto | Health Professions | Best Researcher Award

Prof. Wing Hong Seto | Health Professions | Best Researcher Award

Prof. Wing Hong Seto, WHO Collaborating Centre for Infectious Diseases Epidemiology and Control, School of Public Health, The University of Hong Kong, Hong Kong

Dr. Seto Wing Hong is a globally acclaimed expert in infection control and epidemiology. He serves as Co-Director of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the University of Hong Kong. With honorary and leadership roles across Asia-Pacific and international institutions, Dr. Seto is a trusted voice in pandemic response, hospital safety, and microbial science. A specialist in clinical microbiology, he has contributed significantly to WHO's COVID-19 response strategies. His distinguished career includes key roles such as Chief Infection Control Officer of the Hospital Authority in Hong Kong, and professor-level appointments in China, Australia, and the U.S. Dr. Seto’s work has been recognized through numerous prestigious awards, including the Bronze and Silver Bauhinia Stars. He continues to shape infection control policy, research, and clinical best practices globally. His dedication exemplifies leadership in the health professions at the highest level.

Professional Profile

Scopus

orcid

Evaluation for the “Research for Best Researcher Award” – Dr. Seto Wing Hong

Summary of Suitability:

Dr. Seto Wing Hong stands out as an exemplary candidate for the Research for Best Researcher Award, bringing an unmatched depth of experience, expertise, and dedication to the field of infectious disease epidemiology and control. With a career spanning over four decades, Dr. Seto has significantly contributed to advancing global infection prevention practices, clinical microbiology, and public health policy. His current leadership as Co-Director of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control at the University of Hong Kong positions him at the forefront of research and policy implementation in pandemic preparedness, infection control, and healthcare safety.

He has held numerous high-impact roles across national and international institutions, including serving as an expert member in several WHO advisory panels related to COVID-19, infection prevention, and public health emergencies. This not only highlights his research influence but also his global leadership and trusted advisory role in shaping real-time public health strategies. His previous roles within the Hospital Authority of Hong Kong, such as Chief Infection Control Officer and Chief of Service in Microbiology, underscore his operational experience in translating research into practice—especially during critical periods such as the SARS outbreak and COVID-19 pandemic.

Education 

Dr. Seto Wing Hong earned his MBBS in 1972, followed by MRCP(UK) and MRCPI in 1981. He furthered his credentials with MRCPath (1984) and FRCPath (1997). He is a Founding Fellow of both FHKCPath (1992) and FHKAM (Pathology) [1993], reflecting his pivotal role in establishing professional standards in pathology in Hong Kong. In 1996, he obtained American Board Certification in Healthcare Quality (CPHQ). His academic excellence was supplemented by advanced training in infection control at CDC Atlanta (1985) and patient safety leadership programs in Chicago (1994) and Department of Veterans Affairs, USA (2002). Clinical attachments at prestigious institutions such as St. Thomas' Hospital (UK) and Stanford University expanded his global perspective. His educational foundation has been instrumental in his thought leadership across clinical microbiology and hospital infection control, helping train generations of professionals across continents.

Professional Experience

Dr. Seto Wing Hong has held transformative roles in public health and clinical governance. He served as Chief Infection Control Officer and Cluster Director of Quality & Risk Management at Queen Mary Hospital and the Hong Kong West Cluster under the Hospital Authority. He also served as Chief of Service in Microbiology, shaping hospital-wide infection control policies. Internationally, he is Co-Director of the WHO Collaborating Centre for Infectious Disease Epidemiology and Control and an Expert Member in several WHO committees. In academia, Dr. Seto is a Clinical Professor (Hon) at HKU and has held visiting professorships across China and Australia. He is also a Medical Advisor to private hospitals in Hong Kong. His consultancy roles in the People’s Liberation Army (PRC) and at UNSW, Australia, reflect his wide-ranging influence. His combined hospital, academic, and global advisory experience marks him as a pioneer in health systems improvement and infectious disease control.

Awards and Recognition

Dr. Seto Wing Hong has been widely recognized for his groundbreaking contributions. He received the Best Paper Award and Research Sponsorships from the Hospital Authority in 1994. He led and contributed to Outstanding Team Awards in 1999 and 2000, highlighting his collaborative excellence. For his heroic leadership during SARS, he was awarded the Special SARS Commendation Medal and the Hong Kong West Gold Badge in 2003. These honors were followed by the Bronze Bauhinia Star (2004) and Silver Bauhinia Star (2011), prestigious honors from the Hong Kong SAR Government. In 2012, he was recognized as a Distinguished International Fellow of the Infection Control Association of China. His affiliations with the F1000Prime Faculty since 2014 further validate his scientific impact. These accolades reflect Dr. Seto’s unparalleled dedication to public health, quality care, and infectious disease prevention.

Research Skill On Health Professions

Dr. Seto Wing Hong is a world leader in infection prevention, epidemiology, and clinical microbiology. His research focuses on nosocomial infections, hand hygiene, and pandemic preparedness, having contributed extensively during SARS and COVID-19. As an expert member of multiple WHO advisory panels, his insights shape global infection control strategies. His scientific training is backed by work in high-risk environments, contributing to hospital design, airflow systems, and engineering controls in health settings. Dr. Seto integrates clinical insight with systems thinking, applying quality improvement (CQI) tools for enhanced safety. His work spans microbiological diagnostics, healthcare-associated infections (HAIs), and environmental hygiene innovations. He is skilled in translating evidence into policy, making him an asset for health ministries, hospitals, and international bodies. His mentorship has developed leaders in infection control across Asia-Pacific. A systems thinker and evidence-based strategist, Dr. Seto stands at the forefront of health research excellence.

  Publication Top Notes

1. Surgical implant sterilization in the Asia–Pacific region: A survey of current practices
2. Effective risk management strategy prevented severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission in three private hospitals in Hong Kong throughout the pandemic
  • Authors: Wing Hong Seto, Patricia T.Y. Ching, Andy M.W. Leung, August W.M. Fok, Shing Cheung, Eddie W.Y. Cheung, Clara D.K. Kwok, Kenneth H.L. Tsang, Benjamin J. Cowling

  • DOI: 10.1017/ice.2021.500

  • Year: 2022

3. Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017–2019
  • Authors: James A. Karlowsky, Sibylle H. Lob, Aaron Khan, Wei-Ting Chen, Patrick C.Y. Woo, Wing Hong Seto, Margaret Ip, Stanley Leung, Queenie W.-L. Wong, Rene W.Y. Chau, et al.

  • DOI: 10.1099/jmm.0.001487

  • Year: 2022

4. Author Correction: Respiratory virus shedding in exhaled breath and efficacy of face masks
  • Authors: Leung N.H.L., Chu D.K.W., Shiu E.Y.C., Chan K.-H., McDevitt J.J., Hau B.J.P., Yen H.-L., Li Y., Ip D.K.M., Peiris J.S.M., et al.

  • DOI: 10.1038/s41591-020-0946-9

  • Year: 2020

5. Erratum: Use of medical face masks versus particulate respirators...
6. Respiratory virus shedding in exhaled breath and efficacy of face masks
  • Authors: Leung N.H.L., Chu D.K.W., Shiu E.Y.C., Chan K.-H., McDevitt J.J., Hau B.J.P., Yen H.-L., Li Y., Ip D.K.M., Peiris J.S.M., et al.

  • DOI: 10.1038/s41591-020-0843-2

  • Year: 2020

7. Use of medical face masks versus particulate respirators...
  • Authors: Conly J., Seto W.H., Pittet D., Holmes A., Chu M., Hunter P.R., Cookson B., et al.

  • DOI: 10.1186/s13756-020-00779-6

  • Year: 2020

8. Are reusable blood collection tube holders the culprit for nosocomial hepatitis C virus transmission?
  • Authors: Tsang D.N.C., Ip M., Chan P.K.S., Ching P.T.Y., Lam H.S., Seto W.H.

  • DOI: 10.1017/ice.2018.302

  • Year: 2019

9. Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3)
  • Authors: Zingg W., Storr J., Park B.J., Jernigan J.A., Harbarth S., Grayson M.L., Tacconelli E., Allegranzi B., Cardo D., Pittet D., et al.

  • DOI: 10.1186/s13756-019-0528-0

  • Year: 2019

10. Determinants of methicillin-resistant Staphylococcus aureus (MRSA) prevalence in the Asia-Pacific region
  • Authors: Lim W.W., Wu P., Bond H.S., Wong J.Y., Ni K., Seto W.H., Jit M., Cowling B.J.

  • DOI: 10.1016/j.jgar.2018.08.014

  • Year: 2019